Minghui Pharmaceutical has reported positive topline outcomes from the randomised Phase III trial of its pan-Jak inhibitor, ...

When the session moderator asked whether the findings meant cardiovascular risk was no longer a worry with JAK inhibitors ...

USA: A recent post hoc analysis of the ORAL Surveillance trial has highlighted the essential role of statins in mitigating major adverse cardiovascular events (MACE) among patients with rheumatoid ...

Patients with IBD don’t face an increased risk for major adverse cardiovascular events when taking Janus kinase inhibitors ...

Get detailed information on Tofacitinib, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated prescription ...